Teva Pharmaceutical Industries (TEVA) Work In Process (2009 - 2018)
Teva Pharmaceutical Industries' (TEVA) quarterly Work In Process came in at $590.0 million in Q4 2018, down 1.17% YoY from $597.0 million in Q4 2017, and down 3.12% on a QoQ basis from $609.0 million in Q3 2018.
Teva Pharmaceutical Industries (TEVA) Work In Process (2009 - 2018) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has 10 years of Work In Process data on file, last reported at $590.0 million in Q4 2018.
- Quarterly Work In Process fell 1.17% year-over-year to $590.0 million in Q4 2018, while the trailing twelve-month figure through Dec 2018 was $590.0 million (down 1.17% YoY) and the FY2018 annual result came in at $590.0 million, down 1.17% from the prior year.
- Work In Process declined to $590.0 million in Q4 2018, from $609.0 million in the prior quarter.
- In the past five years, Work In Process ranged from a high of $734.0 million in Q2 2014 to a low of $475.0 million in Q2 2016.
- A 5-year average of $609.9 million and a median of $607.0 million in 2015 frame the typical range for Work In Process.
- Annual changes were most pronounced in 2016 — Work In Process dropped 25.31% — and 2017, when it rose 27.37%.
- Tracing TEVA's Work In Process over 5 years: stood at $638.0 million in 2014, then retreated by 16.14% to $535.0 million in 2015, then grew by 0.56% to $538.0 million in 2016, then rose by 10.97% to $597.0 million in 2017, then retreated by 1.17% to $590.0 million in 2018.
- The last three Work In Process figures came in at $590.0 million (Q4 2018), $609.0 million (Q3 2018), and $605.0 million (Q2 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 590.00 Mn |
| Sep 30, 2018 | 609.00 Mn |
| Jun 30, 2018 | 605.00 Mn |
| Mar 31, 2018 | 646.00 Mn |
| Dec 31, 2017 | 597.00 Mn |
| Sep 30, 2017 | 612.00 Mn |
| Jun 30, 2017 | 605.00 Mn |
| Mar 31, 2017 | 568.00 Mn |
| Dec 31, 2016 | 538.00 Mn |
| Sep 30, 2016 | 637.00 Mn |
| Jun 30, 2016 | 475.00 Mn |
| Mar 31, 2016 | 525.00 Mn |
| Dec 31, 2015 | 535.00 Mn |
| Sep 30, 2015 | 605.00 Mn |
| Jun 30, 2015 | 636.00 Mn |
| Mar 31, 2015 | 648.00 Mn |
| Dec 31, 2014 | 638.00 Mn |
| Sep 30, 2014 | 684.00 Mn |
| Jun 30, 2014 | 734.00 Mn |
| Mar 31, 2014 | 712.00 Mn |